WEKO3
インデックスリンク
アイテム
Current status of research on sarcopenia in post-treatment cancer survivors in Japan: A narrative review
https://fmu.repo.nii.ac.jp/records/2002102
https://fmu.repo.nii.ac.jp/records/20021021af1f62e-fc66-47fe-9123-d1a9fe1cbc31
| 名前 / ファイル | ライセンス | アクション |
|---|---|---|
FksmJMedSci_70_p119.pdf (462.2 KB)
|
|
| Item type | デフォルトアイテムタイプ（フル）fmu(1) | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 公開日 | 2024-07-26 | |||||||||||||||||
| タイトル | ||||||||||||||||||
| タイトル | Current status of research on sarcopenia in post-treatment cancer survivors in Japan: A narrative review | |||||||||||||||||
| 言語 | en | |||||||||||||||||
| 作成者 |
Osaki, Keiichi
× Osaki, Keiichi
× Fukushima, Takuya
× Suzuki, Katsuyoshi
× Kamimura, Akiho
× Yanai, Saki
× Morishita, Shinichiro
|
|||||||||||||||||
| 権利情報 | ||||||||||||||||||
| 権利情報Resource | https://creativecommons.org/licenses/by-nc-sa/4.0/ | |||||||||||||||||
| 権利情報 | © 2024 The Fukushima Society of Medical Science. This article is licensed under a Creative Commons [Attribution-NonCommercial-ShareAlike 4.0 International] license. | |||||||||||||||||
| 内容記述 | ||||||||||||||||||
| 内容記述タイプ | Abstract | |||||||||||||||||
| 内容記述 | Sarcopenia is prevalent among 11-25% of adult cancer survivors, depending on the cancer type, although the available data on post-treatment survivors in Japan are limited. If cancer patients develop cachexia, they may experience sustained weight loss as a result, ultimately leading to sarcopenia. Conversely, some patients experience post-treatment weight gain, resulting in sarcopenic obesity. Both sarcopenia and obesity elevate the risk of cardiovascular diseases and mortality; therefore, the importance of sarcopenia prevention and management is undeniable. The Guidelines for Exercise for Cancer Survivors recommend continued physical activity. Recent studies have reported the effectiveness of multimodal interventions, combining pharmacological, nutritional, and exercise approaches, necessitating multidisciplinary care for post-treatment sarcopenia. Innovative health interventions using mobile devices have also gained attention. However, studies on sarcopenia in post-treatment cancer survivors, especially those regarding exercise interventions, remain scarce in Japan, primarily due to limited insurance coverage for such post-treatment interventions and workforce challenges. It is clear that some cancer survivors have sarcopenia, which can lead to worse survival and secondary illness. While the benefits of exercise are clear, a comprehensive approach to sarcopenia is a further challenge for the future. | |||||||||||||||||
| 出版者 | ||||||||||||||||||
| 出版者 | The Fukushima Society of Medical Science | |||||||||||||||||
| 言語 | ||||||||||||||||||
| 言語 | eng | |||||||||||||||||
| 書誌情報 |
en : Fukushima Journal of Medical Science 巻 70, 号 3, p. 119-131, 発行日 2024 |
|||||||||||||||||
| 関連情報 | ||||||||||||||||||
| 関連タイプ | isIdenticalTo | |||||||||||||||||
| 識別子タイプ | DOI | |||||||||||||||||
| 関連識別子 | https://doi.org/10.5387/fms.23-00019 | |||||||||||||||||
| 関連情報 | ||||||||||||||||||
| 識別子タイプ | PMID | |||||||||||||||||
| 関連識別子 | 38925958 | |||||||||||||||||
| 資源タイプ | ||||||||||||||||||
| 資源タイプ識別子 | http://purl.org/coar/resource_type/c_6501 | |||||||||||||||||
| 資源タイプ | journal article | |||||||||||||||||
| 出版タイプ | ||||||||||||||||||
| 出版タイプ | VoR | |||||||||||||||||
| 出版タイプResource | http://purl.org/coar/version/c_970fb48d4fbd8a85 | |||||||||||||||||
| 収録物識別子 | ||||||||||||||||||
| 収録物識別子タイプ | PISSN | |||||||||||||||||
| 収録物識別子 | 0016-2590 | |||||||||||||||||
| 収録物識別子 | ||||||||||||||||||
| 収録物識別子タイプ | EISSN | |||||||||||||||||
| 収録物識別子 | 2185-4610 | |||||||||||||||||
| 収録物識別子 | ||||||||||||||||||
| 収録物識別子タイプ | NCID | |||||||||||||||||
| 収録物識別子 | AA0065246X | |||||||||||||||||
| 主題 | ||||||||||||||||||
| 主題Scheme | Other | |||||||||||||||||
| 主題 | sarcopenia | |||||||||||||||||
| 主題 | ||||||||||||||||||
| 主題Scheme | Other | |||||||||||||||||
| 主題 | cancer survivors | |||||||||||||||||
| 主題 | ||||||||||||||||||
| 主題Scheme | Other | |||||||||||||||||
| 主題 | type-specific prevalence | |||||||||||||||||
| 主題 | ||||||||||||||||||
| 主題Scheme | Other | |||||||||||||||||
| 主題 | exercise therapy | |||||||||||||||||
| 主題 | ||||||||||||||||||
| 主題Scheme | MeSH | |||||||||||||||||
| 主題 | Sarcopenia | |||||||||||||||||
| 主題 | ||||||||||||||||||
| 主題Scheme | MeSH | |||||||||||||||||
| 主題 | Humans | |||||||||||||||||
| 主題 | ||||||||||||||||||
| 主題Scheme | MeSH | |||||||||||||||||
| 主題 | Cancer Survivors | |||||||||||||||||
| 主題 | ||||||||||||||||||
| 主題Scheme | MeSH | |||||||||||||||||
| 主題 | Japan | |||||||||||||||||
| 主題 | ||||||||||||||||||
| 主題Scheme | MeSH | |||||||||||||||||
| 主題 | Neoplasms | |||||||||||||||||
| 主題 | ||||||||||||||||||
| 主題Scheme | MeSH | |||||||||||||||||
| 主題 | Exercise | |||||||||||||||||
